medigraphic.com
ISSN 2992-7757 (Electronic)
Órgano de difusión de la Asociación Latinoamericana de Cirugía y Traumatología Bucomaxilofacial (ALACIBU)

2022, Number 1

<< Back

Lat Am J Oral Maxillofac Surg 2022; 2 (1)

Management of recurrent parotid pleomorphous adenoma caused by anachronistic lumpectomy. Clinical case report and analytical literature review

Méndez FLMA

Language: Spanish
References: 48
Page: 30-38
PDF size: 461.48 Kb.


ABSTRACT

Pleomorphic adenoma is related to a high recurrence rate. In the past it was linked to lumpectomy. The purpose of this article is to show why lumpectomies fail by showing its consequences: recurrent pleomorphic adenoma, difficult management due to its multinodularity and fibrosis, possibility of malignancy after repeated surgeries. The failure of this case was due to the lumpectomy that caused two tumor recurrences, both a year after surgery, with peripheral multinodular dissemination. The total parotidectomy with sparing facial nerve, offered favorable results and with 42 months of evolution there is no facial palsy and there is no evidence of tumor recurrence. The treatment of recurrent pleomorphic adenoma is not standardized, and it can be managed with total parotidectomy, prolonged follow-up, and the use of adjuvant radiotherapy. It is recommended, not incisional biopsies, conventional parotidectomy with preservation of the facial nerve to avoid tumor recurrence as far as possible.


REFERENCES

  1. Zernial O, Springer IN, Warnke P, Harle F, Risick C, Wiltfang J. Long-term recurrence rate of pleomorphic adenoma and postoperative facial nerve paresis (in parotid surgery). J Craniomaxillofac Surg. 2007; 35: 189-192.

  2. Leverstein H, van der Wal JE, Tiwari RM, van der Waal I, Snow GB. Surgical management of 246 previously untreated pleomorphic adenomas of the parotid gland. Br J Surg. 1997; 84: 399-403.

  3. Kerawala C, Brennan PA, Cascarini L, Godden D, Coombes D, McCaul J. Management of tumour spillage during parotid surgery for pleomorphic adenoma. Br J Oral Maxillofac Surg. 2014; 52: 3-6.

  4. Foresta E, Torroni A, Di Nardo F, et al. Pleomorphic adenoma and benign parotid tumors: extracapsular dissection vs superficial parotidectomy review of literature and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014; 117: 663-676.

  5. Heyfelder JF. Die versuche mit dem schwefela?ther. Erlangen: Verlag Von Carl Heyder; 1847.

  6. Erichsen JE. The science and art of surgery. Philadelphia: Collins Printer; 1869.

  7. Dell'Aversana Orabona G, Bonavolonta P, Iaconetta G, Forte R, Califano L. Surgical management of benign tumors of the parotid gland: extracapsular dissection versus superficial parotidectomy--our experience in 232 cases. J Oral Maxillofac Surg. 2013; 71: 410-413.

  8. Senn N. The pathology and surgical treatment of tumors. Philadelphia, PA: PW. B. Saunders; 1895.

  9. Donovan D, Conley J. Capsular significance in parotid tumor surgery: Reality and myths of lateral lobectomy. Laryngoscope. 1984; 94: 324-329.

  10. Work WP. Therapy of salivary gland tumors. Arch Oto Head Neck Surg. 1966; 83: 89-91.

  11. Janes RM. The treatment of tumours of the salivary glands by radical excision. Can Med Assoc J. 1940; 43: 554-559.

  12. Bailey H. Treatment of tumours of the parotid gland with special reference to total parotidectomy. Br J Surg. 1941; 28: 337-346.

  13. Martin H. The operative removal tumors of the parotid salivary gland. Surgery. 1952; 31: 670-682.

  14. Liu H, Pei J, He Y, Lan X, Sun R, Deng T, et al. Comparison of functional change in parotid gland after surgical excision of pleomorphic adenoma by two different types of parotidectomy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 1223 85-91.

  15. Rodriguez-Bigas MA, Sako K, Razack MS, Shedd DP, Bakamjian VY. Benign parotid tumors: a 24 year experience. J Surg Oncol. 1991; 46: 159-161.

  16. Kanatas A, Ho MWS, Mücke T. Current thinking about the management of recurrent pleomorphic adenoma of the parotid: a structured review. Br J Oral Maxillofac Surg. 2018; 56: 243-248.

  17. Becelli R, Morello R, Renzi G, Matarazzo G, Dominici C. Recurrent pleomorphic adenoma of the parotid gland: role of neutron radiation therapy. J Craniofac Surg. 2012; 23: e449-e450.

  18. Witt RL, Eisele DW, Morton RP, Nicolai P, Poorten VV, Zbaren P. Etiology and management of recurrent parotid pleomorphic adenoma. Laryngoscope. 2015; 125: 888-893.

  19. Niparko JK, Beauchamp ML, Krause CJ, Baker SR, Work WP. Surgical treatment of recurrent pleomorphic adenoma of the parotid gland. Arch Otolaryngol Head Neck Surg. 1986; 112(11): 1180-1184.

  20. Albergotti WG, Nguyen SA, Zenk J, Gillespie MB. Extracapsular dissection for benign parotid tumors: a meta-analysis. Laryngoscope. 2012; 122: 1954-1960.

  21. Patey DH, Thackray AC. The treatment of parotid tumours in the light of a pathological study of parotidectomy material. Br J Surg. 1958; 45: 477-487.

  22. Witt RL. The significance of the margin in parotid surgery for pleomorphic adenoma. Laryngoscope. 2002; 112: 2141-2154.

  23. Park GC, Cho KJ, Kang J, Roh JL, Choi SH, Kim SY, et al. Relationship between histopathology of pleomorphic adenoma in the parotid gland and recurrence after superficial parotidectomy. J Surg Oncol. 2012; 106: 942-946.

  24. Maahs GS, Oppermann Pde O, Maahs LG, Machado Filho G, Ronchi AD. Parotid gland tumors: a retrospective study of 154 patients. Braz J Otorhinolaryngol. 2015; 81: 301-306.

  25. Beahrs OH. Parotid tumors and their surgical management. Am Surg. 1957; 23 (10): 891-899.

  26. Buxton R, Maxwell J, French A. Surgical treatment of epithelial tumors of the parotid gland. Surg Gynecol Obstet. 1953; 97: 401-416.

  27. Zbaren P, Stauffer E. Pleomorphic adenoma of the parotid gland: histopathologic analysis of the capsular characteristics of 218 tumors. Head Neck. 2007; 29: 751-757.

  28. Valstar MH, Ridder M, van den Broek EC, Stuiver MM, van Dijk BAC, van Velthuysen MLF, et al. Salivary gland pleomorphic adenoma in the Netherlands: A nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and the risk factors for recurrence. Oral Oncol. 2017; 66: 93-99.

  29. Zbaren P, Vander Poorten V, Witt RL, Woolgar JA, Shaha AR, Triantafyllou A, et al. Pleomorphic adenoma of the parotid: formal parotidectomy or limited surgery? Am J Surg. 2013; 205: 109-118.

  30. Rowley H, Murphy M, Smyth D, et al. Recurrent pleomorphic adenoma: uninodular versus multinodular disease. Ir J Med Sci. 2000; 169: 201-203.

  31. Renehan A. Treatment of recurrent pleomorphic adenomas. In: McGurk M, Combes J. Controversies in the management of salivary gland disease. 2nd ed. Oxford University Press; 2013.

  32. Maynard JD. Management of pleomorphic adenoma of the parotid. Br J Surg. 1988; 75: 305-308.

  33. Woods JE. Parotidectomy versus limited resection for benign parotid masses. Am J Surg. 1985; 149: 749-750.

  34. O'Dwyer PJ, Farrar WB, Finkelmeier WR, McCabe DP, James AG. Facial nerve sacrifice and tumor recurrence in primary and recurrent benign parotid tumors. Am J Surg. 1986; 152: 442-445.

  35. Stevens KL, Hobsley M. The treatment of pleomorphic adenomas by formal parotidectomy. Br J Surg. 1982; 69: 1-3.

  36. Papadogeorgakis N. Partial superficial parotidectomy as the method of choice for treating pleomorphic adenomas of the parotid gland. Br J Oral Maxillofac Surg. 2011; 49: 447-450.

  37. Abu-Ghanem Y, Mizrachi A, Popovtzer A, et al. Recurrent pleomorphic adenoma of the parotid gland: institutional experience and review of the literature. J Surg Oncol. 2016; 114: 714-718.

  38. State D, Grage TB. Surgical treatment of parotid tumors. Curr Probl Surg. 1966; 3: 3-67.

  39. Andreasen S, Therkildsen MH, Bjorndal K, et al. Pleomorphic adenoma of the parotid gland 1985–2010: a Danish nationwide study of incidence, recurrence rate, and malignant transformation. Head Neck. 2016; 38(suppl 1): E1364-E1369.

  40. Makeieff M, Pelliccia P, Letois F, et al. Recurrent pleomorphic adenoma: results of surgical treatment. Ann Surg Oncol. 2010; 17: 3308-3313.

  41. O'Regan B, Bharadwaj G. Tumour recurrence after surgical removal of parotid pleomorphic salivary adenoma using a retrograde facial nerve dissection technique. Br J Oral Maxillofac Surg. 2012; 50: 417-419.

  42. Renehan A, Gleave EN, McGurk M. An analysis of the treatment of 114 patients with recurrent pleomorphic adenomas of the parotid gland. Am J Surg. 1996; 172: 710-714.

  43. Samson MJ, Metson R, Wang CC, et al. Preservation of the facial nerve in the management of recurrent pleomorphic adenoma. Laryngoscope. 1991; 101: 1060-1062.

  44. Wallace AS, Morris CG, Kirwan JM, Werning JW, Mendenhall WM. Radiotherapy for pleomorphic adenoma. Am J Otolaryngol. 2013; 34: 36-40.

  45. Phillips PP, Olsen KD. Recurrent pleomorphic adenoma of the parotid gland: report of 126 cases and a review of the literature. Ann Otol Rhinol Laryngol. 1995; 104: 100-104.

  46. Wittekindt C, Streubel K, Arnold G, et al. Recurrent pleomorphic adenoma of the parotid gland: analysis of 108 consecutive patients. Head Neck. 2007; 29: 822-828.

  47. Stennert E, Wittekindt C, Klussmann JP, Arnold G, Guntinas-Lichius O. Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study. Laryngoscope. 2004; 114: 158-163.

  48. Piorkowski RJ, Guillamondegui OM. Is aggressive surgical treatment indicated for recurrent benign mixed tumors of the parotid gland? Am J Surg. 1981; 142: 434-436.




2020     |     www.medigraphic.com